Peter Hamley joined AstraZeneca (formerly Astra) after completing a BSc in Chemistry at Imperial College, a PhD at Cambridge University and postdoctoral studies at the University of Pennsylvania. In 2003 he moved to Frankfurt to join Sanofi (formerly Aventis) and lead global chemistry, natural product and antibody drug conjugate departments across Germany, France and the US and has contributed to the advancement of many projects into clinical development across multiple therapeutic areas. More recently in Business Development he has responsibility for external partnering in drug discovery and has a strong interest in new business models, disruptive technology including AI and open innovation in R&D. He holds an MBA from Bath University.
MEET PETER HAMLEY @ #KFG2019
Peter Hamley will give a plenary talk and will be part of the plenary panel in the AM plenary session.
"Digital and AI innovation in Sanofi"